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In the forming vertebrate heart, bone morphogenetic protein signaling induces expression of the early cardiac regulatory
gene nkx-2.5. A similar regulatory interaction has been defined in Drosophila embryos where Dpp signaling mediated by the
Smad homologues Mad and Medea directly regulates early cardiac expression of tinman. A conserved cluster of Smad
consensus binding sequences was identified in early cardiac regulatory sequences of the mouse nkx-2.5 gene. The
importance of the nkx-2.5 Smad consensus region in early cardiac gene expression was examined in transgenic mice and in
cultured mouse embryos. In transgenic mice, deletion of the Smad consensus region delays induction of embryonic
Smadnkx-2.5/lacZ gene expression during early heart formation. Induction of Smadnkx-2.5/lacZ expression is also
delayed in the outflow tract myocardium and visceral mesoderm. Targeted mutation of the three Smad consensus sequences
inhibited nkx-2.5/lacZ expression in the cardiac crescent, demonstrating a specific requirement for the Smad consensus
sites in early cardiac gene induction. Cultured Smadnkx-2.5/lacZ transgenic mouse embryos also exhibit delayed
induction of transgene expression. In the four-chambered heart, deletion of the Smad consensus region resulted in expanded
Smadnkx-2.5/lacZ transgene expression. Thus, the nkx-2.5 Smad consensus region can have positive or negative
regulatory function, depending on the developmental context and cellular environment. © 2002 Elsevier Science (USA)
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Early in vertebrate development, the cardiac lineage is
among the first specialized cell types to be established in
the embryo. Expression of nkx-2.5 (Csx-1), a homologue of
the Drosophila gene tinman (tin), is an early indicator of
cardiogenesis (Lints et al., 1993; Komuro and Izumo, 1993;
Harvey, 1996; Schultheiss et al., 1995). In Drosophila em-
bryos, tin function is required for cardiac lineage develop-
ment (Azpiazu and Frasch, 1993; Bodmer, 1993). In mice,
Nkx-2.5 has an important role in heart development be-
cause mutation of nkx-2.5 results in cardiac defects and
embryonic lethality (Lyons et al., 1995; Tanaka et al., 1999).
Similarly, mutations in human NKX-2.5 have been associ-
ated with certain forms of congenital heart disease (Schott
et al., 1998; Benson et al., 1999). In late gastrulation stage
avian embryos, nkx-2.5 expression in the anterior lateral
mesoderm demarcates the cardiogenic region (Schultheiss
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All rights reserved.et al., 1995; Ehrman and Yutzey, 1999; reviewed in Yutzey
and Kirby, 2002). Later in development, nkx-2.5 is ex-
pressed in other organs, including the stomach, thyroid, and
spleen. The complex temporal and spatial regulation of
nkx-2.5 is indicative of multiple regulatory mechanisms
controlling its gene expression.
Signals important for nkx-2.5 gene activation and car-
diomyogenic lineage induction are active in the anterior
lateral endoderm of gastrulation stage avian embryos
(Schultheiss et al., 1995, 1997; reviewed in Lough and Sugi,
2000). Bone morphogenetic proteins (BMPs) are present in
the anterior lateral heart forming region of gastrulating
chicken embryos and have been implicated in early cardiac
lineage induction (Schultheiss et al., 1997; Andree et al.,
1998; Ehrman and Yutzey, 1999; Schlange et al., 2000).
BMP-2 is expressed in the anterior lateral endoderm and is
sufficient to activate nkx-2.5 gene expression in the ante-
rior cardiogenic mesoderm (Schultheiss et al., 1997; Andree
et al., 1998). Nkx-2.5 gene expression is also regulated by
BMP signaling in the viscera. In the developing avian
stomach and gizzard, treatment with BMP-4 or ectopic5958. E-mail: yutzey@chmcc.org.
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expression of a constitutively active type I BMP receptor
expands the domain of nkx-2.5 gene expression (Smith and
Tabin, 1999; Smith et al., 2000). Therefore, in both the
heart and gut of avian embryos, nkx-2.5 gene induction is
sensitive to BMP signaling. Likewise, in Drosophila em-
bryos, the BMP-related factor Decapentaplegic (Dpp) is
required for tin gene expression in the cardiac and visceral
mesoderm (Frasch, 1995).
Transcriptional regulation in response to BMP signaling
can be mediated by Smad proteins (reviewed in Kawabata et
al., 1998; Massague and Chen, 2000). These proteins were
initially identified in Drosophila and include Mad and
Medea, which mediate Dpp signaling. A Mad/Medea bind-
ing consensus has been characterized for the Drosophila tin
Dpp-responsive element induced in cardiac and visceral
mesoderm precursors (Xu et al., 1998). In vertebrates,
Smads 1 and 5 are pathway-specific activators of BMP
signaling and bind a similar GC-rich consensus sequence
(Yingling et al., 1996; Ishida et al., 2000). Other CAGA
Smad consensus binding sequences have also been identi-
fied for Smads 3 and 4 (Dennler et al., 1998; Zawal et al.,
1998). In addition to positive BMP regulatory mechanisms,
there are multiple negative regulators of BMP signaling
(Massague and Chen, 2000). Smad6, an inhibitory Smad, is
FIG. 1. Clustered Smad consensus sequences are present in the mouse nkx-2.5 early regulatory element. (A) SmadA contains a GC-rich
consensus sequence reported for tin, vestigial, dmef2, and smad6 regulatory sequences (Xu et al., 1998; Kim et al., 1997; Nguyen and Xu,
1998; Ishida et al., 2000). SmadB and SmadC contain CAGA sequences associated with Smad3/4 DNA binding for human c-jun,
plasminogen activator inhibitor, cardiac ankyrin repeat protein, and 2(I)collagen TGF- responsive regulatory sequences (Dennler et al.,
1998; Wong et al., 1999; Chen et al., 2000; Zhang et al., 2000; Kanai et al., 2001). (B) Three Smad consensus sequences are present between
3059 and 3012, relative to the reported nkx-2.5 transcriptional start site (Lyons et al., 1995). This Smad consensus region was deleted
to generate Smadnkx-2.5/lacZ.
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expressed in the developing heart and may repress BMP
signaling after the initiation of cardiac lineage induction
(Yamada et al., 1999). Noggin and chordin also antagonize
BMP signaling and inhibit cardiogenesis and nkx-2.5 gene
induction (Schultheiss et al., 1997; Schlange et al., 2000).
Thus, complex negative and positive effectors of BMP
signaling coordinate gene regulation in response to these
factors throughout embryogenesis.
Several distinct regulatory sequences controlling mouse
nkx-2.5 gene expression during development have been
identified (Searcy et al., 1998; Lien et al., 1999; Reecy et al.,
1999; Tanaka et al., 1999; Schwartz and Olson, 1999). At
least six positive and three negative regulatory regions have
been uncovered that, together, still do not encompass the
entire nkx-2.5 expression domain. From these studies, it is
apparent that multiple complex mechanisms control nkx-
2.5 gene expression during development. Previously, we
identified mouse nkx-2.5 regulatory sequences (3059/
2554) sufficient for gene expression in the heart forming
region when nkx-2.5 is first expressed (Searcy et al., 1998).
Expression from this regulatory element is dependent on
GATA consensus binding sites (Searcy et al., 1998). How-
ever it is unlikely that GATA factors alone control nkx-2.5
gene expression since GATA4/5/6 expression in the heart
forming region is activated at the same time or soon after
nkx-2.5 (K.E.Y., unpublished observations; Schultheiss et
al., 1997). Further sequence analysis revealed a cluster of
three Smad binding consensus sequences in the nkx-2.5
(3059/2554) regulatory element. Strikingly, one of these
is a GC-rich consensus sequence similar to the Dpp-
responsive Mad binding site of Drosophila tin (Xu et al.,
1998). These sequences represent a potential direct target of
BMP-mediated gene activation by Smads in the cardiogenic
region.
The importance of the Smad consensus region in nkx-2.5
gene regulation was examined in transgenic mice and in
cultured transgenic mouse embryos. Deletion of this region
results in early loss of nkx-2.5/lacZ expression in the
FIG. 2. The Smad consensus region is necessary for early nkx-2.5/lacZ expression in the cardiac crescent and linear heart tube. (A–C)
E7.25–E8.5 Smadnkx-2.5/lacZ transgenic embryos. (D–F) Comparable stages of 3059nkx-2.5/lacZ embryos. Arrowheads indicate the
cardiac crescent (A, B, D, E) and anterior linear heart tube (C, F). Arrows in (C), (E), and (F) indicate the left lateral plate mesoderm containing
stomach and spleen progenitors.
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cardiac crescent, outflow tract myocardium, and visceral
mesoderm. Targeted mutation of the three Smad consensus
sites greatly reduces or completely eliminates nkx-2.5/lacZ
gene activity in the cardiac crescent. In cultured transgenic
embryos, expression of the3059nkx-2.5/lacZ transgene as
well as endogenous nkx-2.5 is induced by BMP-2 treatment.
However, removal of the Smad consensus region results in
delayed nkx-2.5/lacZ gene activation in cultured embryos.
A negative regulatory role for the Smad consensus region
was observed in the four-chambered heart. Thus, the Smad
consensus region appears to have both positive and negative
regulatory roles in nkx-2.5 gene expression during develop-
ment.
MATERIALS AND METHODS
Generation and analysis of Smadnkx-2.5/lacZ and
muSmadnkx-2.5/lacZ transgenic mice. A PCR-based strategy
was used to delete bases 3059 to 3012 from the distal end of
3059nkx-2.5/lacZ (Searcy et al., 1998). The resulting construct,
Smadnkx-2.5/lacZ, does not contain the three Smad consensus
sequences located between3059 and3012 (Dennler et al., 1998;
Xu et al., 1998; Ishida et al., 2000). The oligonucleotide CCCTCT-
GTTTGCTTTCTC (3011 to2094) and a primer directed against
the proximal nkx-2.5 sequence were used to amplify nkx-2.5
promoter sequences minus the Smad consensus region. The se-
quence of the entire amplified promoter was verified and linked to
the lacZ reporter gene with SV40 polyadenylation sequences
(Searcy et al., 1998). The Smadnkx-2.5/lacZ transgene was re-
leased with SpeI and NotI and used to generate transgenic mice
(Searcy et al., 1998). Transgenic mice and embryos were identified
by PCR analysis of genomic DNA with PCR primers directed
against the lacZ transgene (Colbert et al., 1996). Staged embryos
were subjected to whole-mount X-gal staining at E7–E14 (Searcy et
al., 1998). Five independent Smadnkx-2.5/lacZ transgenic lines
were established. Three transgenic lines (Lines 21, 69, and 92)
exhibited comparable -galactosidase (-gal) expression patterns
throughout development. 3059nkx-2.5/lacZ embryos (Line 81)
were generated previously (Searcy et al., 1998).
The three Smad consensus sequences located between 3059
and 3012 of 3059nkx-2.5/lacZ were mutated by using the
QuikChange Site Directed Mutagenesis Kit (Stratagene). First, the
oligonucleotide 5-TCC ATC AGC TAC ATG AAG AGT ACA
TTC GCG CTC TA-3 was used to mutate the two CAGA Smad
consensus sequences located at (3035–3031) and (3024–3020),
resulting in muCAGAnkx-2.5/lacZ. Mutagenesis was performed
using 5–10 ng of 3059nkx-2.5/lacZ within pBluescript with 18
PCR cycles of 95°C, 30 s; 55°C, 60 s; 68°C, 18 min. The GC-rich
Smad consensus sequence located between 3059 and 3050 was
then mutated by using 10–75 ng of muCAGAnkx-2.5/lacZ with 18
PCR cycles of 95°C, 30 s; 55°C, 60 s; 68°C, 22 min. The oligonu-
cleotide used to convert the GC-rich Smad site to a SwaI restriction
site was 5-CAC CGC GGT GGC ATT TAA ATT GCT CAT CCA
TC-3 All mutated nucleotides are shown in bold. The resulting
construct muSmadnkx-2.5/lacZ, with all three Smad consensus
sequences mutated, was verified by sequencing, and the transgene
was released by SwaI/NotI digest. F0 transgenic mouse embryos
were generated and harvested on embryonic days 7.5 (n  9
transgenic) or 10.5 (n  6). All F0 embryos were subjected to
whole-mount X-gal staining, and transgenics were subsequently
identified by PCR analysis of genomic DNA with primers directed
against the lacZ transgene.
-Gal enzymatic assays of transgenic mouse embryos. Protein
extracts were prepared from E7–E8 embryos for analysis of -gal
enzymatic activity. Embryos dissected ex utero were incubated in
30–50 l Tropix lysis buffer containing 0.5 mM DTT on ice for
15–20 min. Cultured embryos were incubated for 2 days and then
removed from the chamber slides in 25 l lysis buffer and incu-
bated for 1 h on ice. Embryos were pelleted by centrifugation, and
cell lysates were analyzed for -gal activity in duplicate by using
the Galactostar reagent (Tropix; PE Biosystems), according to the
manufacturer’s instructions. After removal of cell lysates, genomic
DNA was prepared from the embryo pellets for PCR genotyping by
using oligonucleotide primers directed against the lacZ transgene
(Colbert et al., 1996). Chemiluminescence of -gal reaction prod-
ucts was quantified in duplicate by using a Monolight 3010
luminometer (PharMingen). Statistical significance of observed
differences in -gal activity was determined by Student’s t tests
with P  0.05.
Mouse embryo cultures. Gastrulation-stage FVBN mouse em-
bryos (E7.25) were isolated after timed matings and placed in
culture. Cultured embryos were derived from matings of homozy-
gous 3059nkx-2.5/lacZ transgenic males or heterozygous
Smadnkx-2.5/lacZ males with nontransgenic FVBN females.
Mice were left together overnight and the early morning of the
copulation plug was considered E0.25. After 7 days, the pregnant
females were sacrificed by CO2 asphyxiation and embryos were
dissected into warm culture medium [high glucose DMEM plus
10% fetal bovine serum, 2 mM L-glutamine, and penicillin (100
U/ml)/streptomycin (100 g/ml) (pen/strep)]. Embryos were staged
according to Downs and Davies (1993), based on morphological
landmarks including the primitive streak, amniotic folds, node,
head process, and allantoic bud. With this timing, E7.25 embryos
are at late streak (LS) to early allantoic bud (EB) stages. Embryos
were partially bisected along the lateral aspect of the cup-shaped
embryo by using tungsten needles. This dissection enables the
whole embryo to lie flat on the culture matrix. The anterior and
posterior regions remain adjoined by the intact primitive streak.
Dissected embryos were transferred to culture medium in
collagen-coated eight-well permanox chamber slides (Nunc) and
incubated for 24–48 h in high humidity at 37°C with 5% CO2. In
some cases, culture medium was supplemented with 200 ng/ml
BMP-2 (R&D Systems). After 1–2 days, cultured embryos were
fixed in 2% paraformaldehyde and stained with X-gal to visualize
-gal protein expression (Mikawa et al., 1991). Alternatively,
embryo extracts were prepared for -gal enzymatic assays as
described above. For Smadnkx-2.5/lacZ cultures, genomic DNA
was prepared from X-gal-stained embryos and the presence of the
lacZ transgene was ascertained by PCR genotyping (Colbert et al.,
1996). For in situ analysis, embryos were fixed overnight in 4%
paraformaldehyde/PBS, and then dehydrated through a methanol/
PBS series. For immunohistochemistry, embryos were fixed for 30
min in 4% paraformaldehyde/PBS and transferred to 70% ethanol.
In situ hybridization and immunohistochemistry. Whole-
mount in situ hybridizations with a mouse nkx-2.5 antisense RNA
probe were performed essentially as described previously (Searcy et
al., 1998; Wilkinson, 1993). Cultured embryos were hybridized in
situ while affixed to chamber slides, and Proteinase K digests were
performed for 5 min prior to prehybridization. Staining reactions
were stopped after approximately 1 h, and hybridized embryos were
postfixed in 4% paraformaldehyde prior to photography. Cultured
embryos affixed to chamber slides were immunostained with
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MF-20 hybridoma supernatant (Developmental Studies Hybridoma
Bank, University of Iowa; Bader et al., 1982) and anti--gal poly-
clonal antisera (Eppendorf - 5 Prime) as described previously
(Yutzey et al., 1995). Corresponding secondary antibodies were
Texas Red-conjugated goat anti-mouse IgG and fluorescein (FITC)-
conjugated goat anti-rabbit IgG (Jackson ImmunoResearch Labora-
tories, Inc.).
RESULTS
Clustered Smad consensus binding sequences are
present in mouse nkx-2.5 regulatory sequences. A target
consensus binding sequence (GCCGnCGc) for Drosophila
MAD and Medea has been reported based on Dpp-
responsive elements in tinman, dmef2, and vestigial genes
(Kim et al., 1997; Xu et al., 1998; Nguyen and Xu, 1998). In
mice, a GCCGnCGC-like motif present in the smad6
promoter is responsive to BMP signals mediated by
Smad1/5 and binds Smad5 and Smad4 (Ishida et al., 2000).
This 7-bp Smad1/5-induced sequence is present with no
mismatches in the mouse nkx-2.5 early cardiac regulatory
element (Fig. 1A). Additional Smad-responsive regulatory
elements containing the consensus CAGA are present in
human plasminogen activator inhibitor type 1, c-jun,
PDGF-B, CARP, and 2procollagen genes (Dennler et al.,
1998; Zawal et al., 1998; Wong et al., 1999; Taylor and
Khachigian, 2000; Chen et al., 2000; Kanai et al., 2001).
Two CAGA consensus sequences are present in addition to
the distal GC-rich site between 3059 and 3012 of the
mouse early cardiac regulatory element. The presence of
three potential Smad-responsive sequences within a short
stretch of DNA is characteristic of genetic elements regu-
lated by Smad-dependent signaling mechanisms (Stroschein
et al., 1999; Johnson et al., 1999). The mouse nkx-2.5 Smad
consensus region sequence is highly conserved in human
nkx-2.5 genomic DNA with 48/50 identical nucleotides
(Turbay et al., 1996; GenBank Accession No. AC008412).
Therefore, the Smad consensus region represents a poten-
tial direct target for BMP-mediated induction of mouse
nkx-2.5 gene expression.
The Smad consensus region is required for early induc-
tion of nkx-2.5 gene expression. The importance of the
Smad consensus region in embryonic gene expression was
examined in transgenic mice. The distal 50 bp containing
the Smad consensus region were deleted from 3059nkx-
2.5/lacZ to produce Smadnkx-2.5/lacZ (Fig. 1B). The
GATA sites required for gene expression from the 3059 to
2554 element remain intact (Searcy et al., 1998). Stable
lines of transgenic mice were generated with Smadnkx-
2.5/lacZ in order to examine transgene expression through-
out embryogenesis. Smadnkx-2.5/lacZ expression was
monitored in parallel with 3059nkx-2.5/lacZ by X-gal
staining of transgenic embryos (Fig. 2). Expression of the
3059nkx-2.5/lacZ transgene containing the Smad consen-
sus region is initiated in the cardiac crescent at the late
head fold stage (Fig. 2D). This timing corresponds to the
initiation of endogenous nkx-2.5 expression (Searcy et al.,
1998). In contrast, no -gal expression was detected for
Smadnkx-2.5/lacZ in transgenic embryos at cardiac cres-
cent stages (Figs. 2A and 2B; E7.25–E7.5). In two indepen-
dent transgenic lines, expression of Smadnkx-2.5/lacZ
was first detected at E8.0 when the heart differentiates (Fig.
2C). In the third transgenic line, Smadnkx-2.5/lacZ ex-
pression was not detected until after formation of the
primitive heart tube at E9.0. Thus, initiation of Smadnkx-
2.5/lacZ expression is delayed during the early stages of
heart formation. Expression of 3059nkx-2.5/lacZ is also
induced in the left lateral splanchnic plate mesoderm,
which contains stomach and spleen progenitors (Figs. 2E
and 2F). No expression of Smadnkx-2.5/lacZ was observed
in the left lateral plate visceral mesoderm at E8–E9. How-
ever, Smadnkx-2.5/lacZ is expressed in the spleen after
E10.5 (Fig. 4A). Thus, Smadnkx-2.5/lacZ expression in the
splenic region is delayed by approximately 3 days relative to
3059nkx-2.5/lacZ. Together, these analyses demonstrate
that deletion of the Smad consensus region results in a
delay in nkx-2.5 gene induction in both cardiac and splenic
progenitor populations.
-Gal enzymatic assays were performed on protein ex-
tracts of individual embryos as a more sensitive assay for
transgene expression and to compare levels of gene expres-
sion in different transgenic lines (Fig. 3). Litters of
3059nkx-2.5/lacZ and Smadnkx-2.5/lacZ embryos were
isolated at approximately E7.25 (LS-OB stages; Downs and
Davies, 1993) and E8.25 (early heart tube). Protein extracts
and genomic DNA were prepared for individual embryos.
-Gal expression was quantified for each embryo by using a
chemiluminescent reporter assay. E7.25 corresponds to the
initiation of endogenous nkx-2.5 gene expression. At this
stage, transgenic 3059nkx-2.5/lacZ embryos exhibit a
statistically significant 2.5-fold increase in -gal enzyme
activity over nontransgenic embryos. No increase in -gal
expression over nontransgenic levels was observed in three
independent transgenic Smadnkx-2.5/lacZ lines. At
E8.25, an approximate 50-fold increase in -gal expression
was observed for 3059nkx-2.5/lacZ transgenic embryos
relative to nontransgenic embryos. For all three Smadnkx-
2.5/lacZ transgenic lines, weak but significant induction of
gene expression also was observed at E8.25. These assays
confirm the delayed activation and necessity of the Smad
consensus region for early embryonic expression from nkx-
2.5 regulatory sequences.
The Smad consensus region is required for repression of
nkx-2.5 regulatory sequences in the right ventricle. After
the heart differentiates, Smadnkx-2.5/lacZ expression
was detected in the outflow tract and right ventricle of the
primitive heart (E10.5) (Fig. 4A). Similar restriction of
transgene expression to the anterior heart also was observed
for 3059nkx-2.5/lacZ (Fig. 4C). However, outflow tract
expression of Smadnkx-2.5/lacZ appeared to be reduced
relative to 3059nkx-2.5/lacZ. This could be due to a delay
in Smadnkx-2.5/lacZ activation in the secondary heart
field that develops into the conotruncal myocardium
(Waldo et al., 2001). At E13.5, expression of 3059nkx-2.5/
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lacZ is restricted to the conotruncal region and right
ventricular lumen of the heart (Fig. 4D; Searcy et al., 1998).
Surprisingly, Smadnkx-2.5/lacZ is expressed throughout
the right ventricular myocardium, but expression was not
detected in the left ventricle (Fig. 4B). The expanded expres-
sion in the E13.5 right ventricle suggests that regulatory
interactions with the Smad consensus region can have both
positive and negative roles in regulating nkx-2.5 gene ex-
pression in the embryonic heart.
Smad consensus sequences are specifically required for
the early cardiac induction of nkx-2.5/lacZ gene expres-
sion. Targeted mutations in the three nkx-2.5 Smad con-
sensus sequences were made in order to determine the
requirement for these sites in the early cardiac induction of
3059nkx-2.5/lacZ. Mutations were introduced in the
most distal GC-rich site Smad consensus sequence and in
the two CAGA sequences to eliminate putative Smad
recognition sites in the Smad consensus region (Fig. 5). The
resulting muSmadnkx-2.5/lacZ sequence has no additional
mutations, and the remaining sequence of 3059nkx-2.5/
lacZ remained intact. Transient transgenic F0 mouse em-
bryos were generated by using muSmadnkx-2.5/lacZ and
were analyzed on E7.5 or E10.5. The embryos were first
subjected to X-Gal staining for visible transgene expression
and were then genotyped. Of the nine transgenic embryos
obtained at E7.5, six exhibited no -gal expression and three
transgenic embryos had barely discernable staining (Fig. 5).
None of the embryos exhibited the significant early cardiac
expression obvious for 3059nkx-2.5/lacZ (Fig. 2E) or en-
dogenous nkx-2.5. In addition, the negligible expression of
muSmadnkx-2.5/lacZ in 3/9 transgenic embryos appeared
to be in the anterior endoderm and not in the overlying
cardiogenic mesoderm. The embryo with the strongest
staining in the anterior intestinal portal is represented in
Fig. 5A. Thus, targeted mutation of the Smad consensus
sequences inhibits early cardiac nkx-2.5/lacZ expression at
E7.5.
Transgenic muSmadnkx-2.5/lacZ F0 mouse embryos also
were analyzed at E10.5. muSmadnkx-2.5/lacZ transgenic
embryos exhibited transgene expression in the outflow
tract and right ventricle of the heart as well as in the spleen
primordium (n  2). The expression of muSmadnkx-2.5/
lacZ in the outflow tract appeared diminished in compari-
son to 3059nkx-2.5/lacZ (Figs. 4C and 5B). A similar loss
FIG. 3. Quantification of -gal enzyme activity of transgenic embryos developing in utero. -Gal enzyme activity was quantified by
chemiluminescent reporter gene assays (Galactostar, Tropix) for individual embryos. Embryonic expression at E7.25 and E8.25 was
determined for 3059nkx-2.5/lacZ (Line 81) embryos relative to three independent transgenic Smadnkx-2.5/lacZ lines (L-21, 69, 92).
E7.25 embryos were at LS/OB stages. Statistical significance of -gal expression relative to nontransgenic embryos was determined by
Student’s t test for each experimental group (n  5–29; P  0.05). Error bars represent SEM. *, statistically significant differences.
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FIG. 4. Deletion of the nkx-2.5 Smad consensus region results in increased gene expression in the four-chambered heart. At E10.5,
expression of Smadnkx-2.5/lacZ expressed 3059nkx-2.5/lacZ in anterior heart (arrowhead) and spleen primordium (small arrow) (A, C).
However, expression of Smadnkx-2.5/lacZ appears to be reduced in the secondary heart field of the conotruncal myocardium. After heart
chamber formation (E13.5), Smadnkx-2.5/lacZ is expressed throughout the right ventricle (B). Expression of 3059nkx-2.5/lacZ is
restricted to the conotruncal region of the E13.5 heart (D).
FIG. 5. Targeted mutation of Smad consensus binding sequences delays early induction of nkx-2.5/lacZ gene expression. Mutations
introduced in3059nkx-2.5/lacZ to generate muSmadnkx-2.5/lacZ are shown in red (see Fig. 1 for native sequence). muSmadnkx-2.5/lacZ
F0 transgenic embryos were examined at E7.5 (A) and E10.5 (B). At E7.5, expression was not detected in the cardiac crescent in 9/9 transgenic
embryos (arrowheads), but -gal activity was detected in the underlying anterior intestinal portal in 1/9 transgenic embryos (A). At E10.5,
muSmadnkx-2.5/lacZ is expressed in the anterior heart tube and spleen primordium (lower arrow) but is diminished in the conotruncal
myocardium (upper arrow) relative to 3059nkx-2.5/lacZ (B; and Fig. 4C).
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in outflow tract expression was observed for Smadnkx-
2.5/lacZ and may represent a requirement for the Smad
consensus sequences in the secondary induction of nkx-2.5
expression in the conotruncal myocardium. Together, these
studies demonstrate that targeted mutation of the three
Smad consensus sequences located in the 50-bp Smad
consensus region results in a delay in nkx-2.5 cardiac
expression. However, these Smad consensus sites do not
appear to be required for later expression in the heart and
spleen.
BMP-2 treatment induces nkx-2.5 gene expression in
cultured mouse embryos. An in vitro mouse embryo
culture system was devised in which to examine the
regulation of nkx-2.5 gene activation (Fig. 6). Transgenic
mice generated with 3059nkx-2.5/lacZ activate -gal ex-
pression in the heart forming region prior to the early head
fold stage (Downs and Davies, 1993; Searcy et al., 1998).
Expression of -gal in these embryos therefore serves as an
easily detectable marker for early nkx-2.5 gene induction.
3059nkx-2.5/lacZ embryos isolated after timed matings
are cultured for 2 days corresponding to E7.25–E9. During
the culture period, the cardiomyogenic lineage is deter-
mined and cardiac-specific gene expression is initiated
(Auda-Boucher et al., 2000). 3059nkx-2.5/lacZ transgenic
embryos were isolated at E7.25 [late streak (LS) to no
allantoic bud (OB) stages; Downs and Davies, 1993] and
placed in culture. After 24–48 h, -gal expression is acti-
vated and beating cardiomyocytes are present. In many
cultured embryos, 3059nkx-2.5/lacZ expression is local-
ized to two heart forming regions similar to the endogenous
nkx-2.5 expression domain determined by in situ hybrid-
ization (Figs. 6A and 6B). Immunohistological analyses
demonstrate that 3059nkx-2.5/lacZ expression is colocal-
ized with contractile protein gene expression in the same
embryo (Figs. 6C and 6D). Thus, -gal expression in cul-
tured3059nkx-2.5/lacZ embryos is representative of early
induction of nkx-2.5 gene expression.
The ability of BMP-2 to activate expression of3059nkx-
2.5/lacZ or the endogenous nkx-2.5 gene was examined in
cultured transgenic embryos (Fig. 7). 3059nkx-2.5/lacZ
embryos were isolated at the LS stage and treated with
BMP-2 (200 ng/ml). In control embryos, -gal expression is
restricted to the cardiogenic region (Figs. 6A and 6B). For the
majority of BMP-2-treated embryos, localization of -gal
expression appeared to be increased relative to untreated
embryos (Figs. 7A and 7B). In 6/10 X-gal-stained cultured
FIG. 6. Expression of 3059nkx-2.5/lacZ in cultured mouse embryos colocalizes with the cardiomyogenic lineage. Embryos were staged
according to Downs and Davies (1993) prior to dissection. (A) X-Gal staining of no bud (OB) stage transgenic embryo cultured for 2 days.
(B) In situ hybridization of cultured OB embryo with nkx-2.5 antisense RNA probe. (C, D) Antibody colocalization of -gal (C) and MF-20
reactive sarcomeric myosin heavy chain expression (D) in the same early head fold (EHF) cultured embryo. Arrows in each panel indicate
the cardiogenic region.
250 Liberatore et al.
© 2002 Elsevier Science (USA). All rights reserved.
embryos, there was an apparent expansion of -gal expres-
sion relative to untreated embryos. Similarly, increased
expression of the endogenous nkx-2.5 gene was detected in
nontransgenic embryos treated with BMP-2 in parallel
experiments (Figs. 7C and 7D). In both cases, only a limited
region of the embryo was capable of activating nkx-2.5 gene
FIG. 7. BMP-2 treatment has a limited ability to activate 3059nkx-2.5/lacZ or endogenous nkx-2.5 expression. Late streak stage
3059nkx-2.5/lacZ transgenic embryos (A, B) or nontransgenic embryos (C, D) were cultured in the absence (A, C) or presence (B, D) of
BMP-2 (200 ng/ml). Embryos were isolated at the LS stage and cultured as described in Fig. 6. For treated embryos, BMP-2 was included
throughout the culture period. After 2 days, cultured transgenic embryos were stained with X-gal or prepared for embryo extracts. Six of
ten treated embryos exhibited apparent expansion of 3059nkx-2.5/lacZ expression by X-gal staining. (Arrows indicate paired cardiogenic
regions). (C, D) In situ hybridizations were performed with digoxigenin-labeled nkx-2.5 riboprobe on nontransgenic embryos (arrows
indicate nkx-2.5 expression). (E) -Gal enzymatic activity was determined for treated and untreated 3059nkx-2.5/lacZ (L-81) and
nontransgenic (ntg) embryos. Statistical significance of -gal expression of BMP-2-treated relative to untreated control embryos was
determined by Student’s t test for each experimental group (n  4–6; P  0.05). *, statistically significant difference.
251nkx-2.5 Gene Induction
© 2002 Elsevier Science (USA). All rights reserved.
regulatory sequences. Thus, BMP-2 alone is sufficient to
activate 3059nkx-2.5/lacZ or endogenous nkx-2.5 only in
a limited population of cells in the murine embryo.
Nkx-2.5/lacZ gene expression in cultured embryos was
quantified by using chemiluminescent reporter assays for
-gal enzyme activity. A statistically significant 60% in-
crease in -gal activity was observed for BMP-2-treated
embryos relative to untreated transgenic controls (Fig. 7E).
The increase in 3059nkx-2.5/lacZ expression in response
to BMP-2 likely represents expanded activation of nkx-2.5
gene expression within the region of cardiogenic potential.
In comparably staged avian embryos, only the anterior
medial mesoderm activates nkx-2.5 expression when
treated with BMP-2 alone (Schultheiss et al., 1997; Andree
et al., 1998; Schlange et al., 2000). Thus, in cultured
transgenic mouse embryos, induction of 3059nkx-2.5/
lacZ is similarly restricted in the embryo even in the
presence of ubiquitous BMP-2.
Induction of Smadnkx-2.5 gene expression is delayed
in cultured transgenic mouse embryos. The requirement
for the Smad consensus region in early nkx-2.5 gene induc-
tion was further examined in cultured transgenic embryos.
After 1 day in culture, 3059nkx-2.5/lacZ is easily detect-
able by X-gal staining of transgenic embryo cultures (Fig.
8C). In contrast, minimal X-gal staining was observed after
1 day for Smadnkx-2.5/lacZ embryos (Fig. 8A). After 2
days, -gal expression levels in cultured embryos are con-
sistent with expression observed in differentiated heart
tubes of corresponding Smadnkx-2.5/lacZ embryos devel-
oping in utero. Thus, the reduced early expression of
Smadnkx-2.5/lacZ represents a delay in gene activation
relative to 3059nkx-2.5/lacZ in cultured embryos. These
analyses support the importance of the clustered Smad
consensus sequences in the early embryonic induction of
nkx-2.5 gene expression.
DISCUSSION
A potential Smad responsive region was identified in
early cardiac regulatory sequences of mouse nkx-2.5. This
region contains three Smad DNA binding consensus se-
quences based on homology with confirmed vertebrate
Smad binding sites. One of the nkx-2.5 Smad sequences has
high identity with Mad/Medea binding sites in Dpp-
responsive sequences of Drosophila tin (Xu et al., 1998;
Dennler et al., 1998; Ishida et al., 2000). In transgenic mice,
the nkx-2.5 Smad consensus region is required for the
initial induction of gene expression in the forming heart
and visceral mesoderm. Smadnkx-2.5/lacZ embryos ex-
hibit a delay in reporter gene activation relative to
3059nkx-2.5/lacZ embryos in the heart primordia,
conotruncal myocardium, and visceral mesoderm. Targeted
mutation of the three Smad sites inhibits induction of
nkx-2.5 transgene expression in the cardiac crescent. Later
in development, the Smad consensus sites are not required
for nkx-2.5/lacZ gene expression in the heart or spleen
primordium. A potential negative regulatory function of the
Smad consensus region was apparent in Smadnkx-2.5/
lacZ expression in the right ventricle of the heart. Experi-
ments in cultured embryos demonstrated that BMP-2 is
sufficient to activate 3059nkx-2.5/lacZ and endogenous
nkx-2.5 gene expression in a subset of cells in the embryo.
However, deletion of the Smad consensus region results in
a delay in Smadnkx-2.5/lacZ induction in cultured em-
bryos. These data are consistent with distinct Smad-
dependent and -independent regulatory mechanisms con-
trolling nkx-2.5 gene expression during development.
Complex regulatory elements control mouse nkx-2.5
gene expression during development. The temporal and
spatial regulation of nkx-2.5 gene expression during mouse
development involves several distinct cis-acting regulatory
elements (reviewed in Schwartz and Olson, 1999). Two
cardiac regulatory elements located approximately 3 and 10
kb 5 to the nkx-2.5 transcriptional start site have been
identified (Searcy et al., 1998; Lien et al., 1999; Reecy et al.,
1999; Tanaka et al., 1999; Schwartz and Olson, 1999). Both
of the cardiac regulatory elements are dependent on GATA
consensus binding sites for gene activity. In previous stud-
ies, expression of the 3059/2554 regulatory element was
sufficient for the initial induction of nkx-2.5 gene expres-
sion in the heart, pharynx, and spleen progenitors (Searcy et
al., 1998). This element is highly conserved in human and
Xenopus genomic sequence of the nkx-2.5 locus (Turbay et
al., 1996; Sparrow et al., 2000). In transgenic Xenopus
embryos, the homologous nkx-2.5 element is also GATA-
dependent and is sufficient for gene expression throughout
the embryonic heart. However, in transgenic mice, the
Xenopus element activates gene expression in the same
anterior segments of the heart as the 3059/2554 mouse
nkx-2.5 sequence (Searcy et al., 1998; Sparrow et al., 2000).
Thus the 3059/2554 mouse nkx-2.5 regulatory element
and its Xenopus homologue are sufficient for gene activa-
tion in early cardiac and visceral mesoderm progenitors and
their derivatives. The early cardiac and visceral expression
of mouse 3059nkx-2.5/lacZ is comparable to the dorsal
mesoderm expression of the Drosophila tin Dpp-responsive
regulatory element (Xu et al., 1998).
In the present study, a potential Smad-responsive region
(3059 to 3011) was identified within the early cardiac
and splenic regulatory element of the mouse nkx-2.5 gene
(Lyons et al., 1995; Searcy et al., 1998). This sequence is
required for the initial induction of nkx-2.5/lacZ expression
in the heart and spleen and targeted mutation of the Smad
sites results in the loss of early cardiac gene expression. The
same sequence appears to have a negative regulatory role in
the right ventricle of the heart. The requirement for the
Smad consensus region for early, but not later, cardiac
expression is suggestive of different regulatory interactions
acting on the same element over time. Previous studies
demonstrated that this same regulatory region requires
paired GATA sites for its expression (Searcy et al., 1998).
Therefore, the initiation of cardiac and splenic gene expres-
sion regulated by the 3059/2554 sequence requires the
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Smad consensus region but maintenance requires GATA
interactions. A Smad consensus sequence that binds Smad4
is located adjacent to these GATA sites and is required for
expression early in the cardiac crescent and later in the
differentiated heart of transgenic embryos (Lien et al.,
2002). Distinct regulatory mechanisms controlling early
cardiac and visceral mesoderm vs differentiated cardiocyte
expression have also been demonstrated for Drosophila tin
(Xu et al., 1998). Thus, there is evidence in both flies and
mice that distinct regulatory programs control tinman/nkx-
2.5 expression in the cardiogenic and visceral mesoderm vs
differentiated cardiac myocytes.
Induction of nkx-2.5 expression is mediated by BMPs in
the heart and gut. In chicken embryos, BMP-2 and -7 are
expressed in the cardiogenic region, and nkx-2.5 gene ex-
pression is activated with BMP-2 treatment (Schultheiss et
al., 1997; Andree et al., 1998). In cardiogenic P19CL6 cells,
BMP signaling mediated by TAK1 and Smads is required for
cardiac differentiation (Monzen et al., 1999, 2001). Recent
studies have identified a second cardiogenic field in the
pharynx and outflow tract of avian embryos (Waldo et al.,
2001; reviewed in Yutzey and Kirby, 2002). BMP-2 is
expressed in the adjacent pharyngeal endoderm, and noggin
treatment inhibits secondary cardiomyogenesis in the
conotruncal myocardium (Waldo et al., 2001). In the avian
gut, BMP-4 signaling through BMPR1 induces of nkx-2.5
gene expression in the pyloric sphincter (Smith and Tabin,
1999; Smith et al., 2000). Therefore, BMPs are present in the
developing heart and viscera when nkx-2.5 gene expression
is initiated. None of these studies demonstrated a direct
regulation of nkx-2.5 gene expression by Smads. However,
direct binding of Smad homologues to Drosophila tin regu-
FIG. 8. Smadnkx-2.5/lacZ is expression is delayed relative to 3059nkx-2.5/lacZ in early stage cultured mouse embryos. Smadnkx-
2.5/lacZ LS embryos were cultured for 1 (A) or 2 (B) days and stained with X-gal. 3059nkx-2.5/lacZ LS embryos were cultured for 1 (C)
or 2 (D) days. Arrows in each panel indicate -gal expression consistent with heart forming region. The delay in Smadnkx-2.5/lacZ
activation in cultured embryos is consistent with initiation of transgene expression in the differentiated heart tube of embryos developing
in utero (Fig. 2).
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latory sequences is required for induction of gene expres-
sion by Dpp in cardiac and visceral mesoderm (Xu et al.,
1998). In this study, we demonstrate that deletion or
mutation of Smad consensus binding sequences in the
mouse nkx-2.5 gene inhibits gene activation in cardiac and
visceral mesoderm. An additional Smad binding site in the
3059/2554 regulatory region also is required for nkx-2.5
transgene expression in the developing heart (Lien et al.,
2002). These observations are initial evidence that these
nkx-2.5 regulatory sequences represent a direct down-
stream target of BMP signaling mediated by Smads.
Regulation of gene expression by Smads. Smad1 and
Smad5 are associated with BMP-mediated signal transduc-
tion in several developmental systems, and both are ex-
pressed in the cardiogenic region of early stage avian and
mouse embryos (data not shown; and Hata et al., 1998;
Chen et al., 1998; Whitman, 1998; Yamada et al., 1999;
Chang et al., 1999). Targeted mutation of smad5 in mice
results in embryonic lethality in homozygous mutant em-
bryos with defects in cardiac development similar to those
observed for BMP-2 mutant embryos (Chang et al., 1999;
Zhang and Bradley, 1996). In Xenopus embryos, inhibition
of BMP-mediated induction of cardiogenesis can be over-
come by ectopic expression of XSmad1 (Shi et al., 2000).
Together, these studies provide evidence for a role of Smads
1 and 5 in mediating BMP-2 induction of early cardiac gene
expression. Smads 1 and 5 regulate mouse smad6 gene
expression by binding the sequence GCCGCGCC (Ishida et
al., 2000). This sequence is present in the nkx-2.5 Smad
consensus region at 3059 to 3050. The nkx-2.5 Smad
consensus region also contains two CAGA sequences. Simi-
larly clustered CAGA and GC-rich Mad/Medea binding
sites are required for dorsal mesodermal expression of a
Drosophila even-skipped regulatory element (Knirr and
Frasch, 2001). In vertebrates, Smads 3 and 4 have been
shown to bind and activate CAGA sequences in the human
PAI-type 1 and 2(I)-collagen genes in response to TGF-
signaling (Zawal et al., 1998; Dennler et al., 1998; Zhang et
al., 2000). Nkx-2.5 gene expression has not previously been
shown to be regulated through TGF- or Activin signaling.
However, the presence of multiple potential Smad target
sequences in nkx-2.5 regulatory sequences and the complex
pattern of nkx-2.5 gene expression support regulation by
multiple TGF- superfamily members.
The nkx-2.5 Smad consensus region between 3059 and
3011 appears to have a negative role in nkx-2.5 gene
regulation in the right ventricle of the heart. This observa-
tion suggests that the nkx-2.5 Smad consensus region can
mediate either the induction or repression gene expression
at different times and in different tissues during embryo-
genesis. In general, Smads bind DNA weakly and require
cofactors for their gene regulatory activity (reviewed in
Attisano and Wrana, 2000). In some cases, Smad interac-
tions with the same cis-acting element can activate or
inhibit gene expression depending on the Smad partners
(Labbe et al., 1998; Wotton et al., 1999). The complex
regulation of the nkx-2.5 Smad consensus region in trans-
genic mice is initial evidence for different Smad cofactors in
the cardiogenic region versus the differentiated heart. The
high degree of nucleotide identity throughout this region
between mouse and human genomic sequences also may be
indicative of conserved Smad cofactor interactions. Al-
though there are no obvious consensus binding sites for
previously identified Smad cofactors in the Smad consensus
regulatory region, it seems likely that the developmental
regulation of nkx-2.5 gene expression involves complex
protein interactions on this cis-element.
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